Form 4: Vaxart SVP Sean Tucker Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Sean Tucker, SVP and Chief Scientific Officer of Vaxart, Inc., reports a transaction involving the withholding of shares to cover income tax obligations related to vested RSUs.
Summary
- On March 28, 2025, Sean Tucker, SVP and Chief Scientific Officer of Vaxart, Inc., had 3,913 common stock shares withheld by the issuer to satisfy income tax obligations related to the net settlement of vested Restricted Stock Units (RSUs).
- Following the transaction, Tucker directly owns 740,490 shares of Vaxart common stock.
- Tucker also indirectly owns 51,465 shares through joint tenancy with Frances Chang and Sean Tucker, and 9,060 shares through his spouse.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard tax withholding procedures. It doesn't indicate positive or negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are routine and provide transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 03/28/2025 | Date of transaction involving the withholding of shares for tax obligations. |
| 04/01/2025 | Date of signature on the Form 4 filing. |
Keywords
Vaxart, Sean Tucker, Beneficial Ownership, Form 4, RSUs, Tax Withholding, VXRT, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.